about
Cell therapies for pancreatic beta-cell replenishmentStem cell therapy to cure type 1 diabetes: from hype to hope.Regenerative medicine in diabetesDelayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal modelConcise review: clinical programs of stem cell therapies for liver and pancreasAlginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression.Enhancement of mouse germ cell-associated genes expression by injection of human umbilical cord mesenchymal stem cells into the testis of chemical-induced azoospermic mice.Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-upMesenchymal stem cells: potential application in intervertebral disc regeneration.Genetic stability of pluripotent stem cells during anti-cancer therapiesGene therapy for type 1 diabetes moves a step closer to realityRapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor.Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for possible life-long pancreatic organogenesis.Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in ratsRole of mesenchymal stem cells in cell life and their signaling.Concise review: pluripotent stem cell-based regenerative applications for failing β-cell functionApplicability of adipose-derived stem cells in type 1 diabetes mellitus.Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage.Translation, but not transfection limits clinically relevant, exogenous mRNA based induction of alpha-4 integrin expression on human mesenchymal stem cells.Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression.A modified method of insulin producing cells' generation from bone marrow-derived mesenchymal stem cellsThe Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells.Mesenchymal stem cells moderate immune response of type 1 diabetes.Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases.Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes.Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA.Quantum dots labelling allows detection of the homing of mesenchymal stem cells administered as immunomodulatory therapy in an experimental model of pancreatic islets transplantation.
P2860
Q26741240-9844AA7A-793B-4D99-A022-E5FD867C9CBAQ26823294-D2B4784A-C69A-42EE-BDA6-31318D1BBC14Q26825378-25F864E6-0675-4E8B-920B-940B98294339Q27301248-7E0CB0C6-7D0D-4C81-8683-96B0055D4D33Q30555472-1C12EF34-901A-4E53-A1A9-459C2DD6657CQ34043187-A5F566A7-4438-4DAB-BC78-E0CC757215BBQ34433197-8044EAC6-69E2-4C7F-832D-938992FF194DQ35881106-FE5B8C8B-FBC3-457F-8B4B-8FC6246ABD81Q36508661-4AB86519-E9CD-4396-BA40-9907140706D5Q36639903-855E864B-AB3A-4E61-8D87-F5FEFD751C02Q36796148-8670763A-0E3E-4AA5-8983-CF392EAA42A7Q36810424-873EA15F-D147-4414-BE93-4CDA36B693D2Q37228093-10B705E0-5A30-472B-AE00-F2F0A3AC1A14Q37377889-B5CC2E8D-2B4A-444D-BF43-63F4E81F39B3Q37589437-0310088F-7947-4D75-8973-6536DC7FD3FAQ38197390-58F89931-193B-4C34-9EF3-963300686DA6Q38332629-0AD905AE-CA38-46F1-923B-99CB09AEE590Q38374569-7D508F2F-0802-4EEC-8964-9A356D463592Q38407079-9CB2B5FF-3509-4DF0-9B03-809B229646F9Q38691354-E0C92390-BC85-4C15-A341-C3D083EA53EFQ38936385-D304A42C-0654-491F-BC75-9085D621FB49Q38939711-2B326D1B-4F52-41EE-8D97-AD8ADC141132Q38970616-1E195356-A554-440E-9959-650CB05F631FQ38977465-CEF9E48D-754A-450B-91ED-11D31B984068Q41196008-AB72006E-B213-40B7-9CD2-AB4D1E8ACB7AQ42181651-9D520C82-A038-4A47-92F6-2C18EFFF8F5CQ42425429-41C7E278-AF13-4A4F-AF31-9CD028F67AECQ44363859-6F1C4AFC-881B-447E-BB58-8B62212D2A84Q51097983-A8E88E2B-C99D-4B63-908A-96D6C5595ECE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Concise review: mesenchymal stem cells for diabetes.
@en
Concise review: mesenchymal stem cells for diabetes.
@nl
type
label
Concise review: mesenchymal stem cells for diabetes.
@en
Concise review: mesenchymal stem cells for diabetes.
@nl
prefLabel
Concise review: mesenchymal stem cells for diabetes.
@en
Concise review: mesenchymal stem cells for diabetes.
@nl
P2860
P356
P1476
Concise review: mesenchymal stem cells for diabetes.
@en
P2093
Juan Domínguez-Bendala
Luca Inverardi
P2860
P356
10.5966/SCTM.2011-0017
P577
2011-12-07T00:00:00Z